Advertisement
Screener

Eagle Pharmaceuticals, Inc. Form 10-K/A: Amended annual report

Eagle Pharmaceuticals, Inc. Form 10-K/A: Amended annual report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-05-02: Form 10-K/A; Period of report 2021-12-31; Description FORM 10-K/A; Document tm2214133d3_10ka.htm.
  • 2016-11-30: Form 10-K/A; Period of report 2015-12-31; Description 10-K/A; Document a16-22338_110ka.htm.
  • 2016-04-29: Form 10-K/A; Period of report 2015-12-31; Description 10-K/A; Document a16-9910_110ka.htm.
  • 2015-01-28: Form 10-K/A; Period of report 2014-09-30; Description 10-K/A; Document a10-ka.htm.
FiledFormPeriod of reportDescriptionDocument
2022-05-0210-K/A2021-12-31FORM 10-K/Atm2214133d3_10ka.htm
2016-11-3010-K/A2015-12-3110-K/Aa16-22338_110ka.htm
2016-04-2910-K/A2015-12-3110-K/Aa16-9910_110ka.htm
2015-01-2810-K/A2014-09-3010-K/Aa10-ka.htm